Although a weak impact on nocturia is already known from - adrenoceptor antagonists without subtype selectivity , the individual placebo-controlled studies and the pooled data analysis showed that the 1A-adrenoceptor subtype-selective antagonist silodosin consistently and significantly improves nocturia in men with LUTS/BPH .